RESEARCH SUPPORT

The Propel a Cure organization is pleased and hopeful to be sponsoring the following research.

Propel a Cure is especially excited to be supporting the eminent immunologist, Dr. Mark Davis and his team at Stanford University. If successful, his work will be a game changer!

Research Goal: Identification of circulating and tissue-resident CD4+ T cells specific for disease-driving antigens in Crohn’s disease

Propel a Cure has prioritized the funding of a study that would lead to the identification of circulating and tissue-residant CD4+ T cells specific for disease-driving antigens in Crohn’s disease. T cells are a type of white blood cell that appear to have a major role in the body’s overactive inflammatory response that is seen in Crohn’s.

If you would like to contribute or find out more about this study, please contact or submit your tax-deductible donation through our secure "Network For Good" portal. Thank you!